Pharmacologic evidence for abnormal thalamocortical functioning in GABA receptor beta3 subunit-deficient mice, a model of Angelman syndrome.
about
Epileptic encephalopathy de novo GABRB mutations impair GABAA receptor functionDeletion of Rictor in neural progenitor cells reveals contributions of mTORC2 signaling to tuberous sclerosis complex.Altered GABA(A) receptor subunit expression and pharmacology in human Angelman syndrome cortex.Hyperglycosylation and reduced GABA currents of mutated GABRB3 polypeptide in remitting childhood absence epilepsy.Behavior and neuropsychiatric manifestations in Angelman syndrome.Relationship between aberrant brain connectivity and clinical features in Angelman Syndrome: a new method using tract based spatial statistics of DTI color-coded orientation maps.Development and Experimental Validation of a Dry Non-Invasive Multi-Channel Mouse Scalp EEG Sensor through Visual Evoked Potential Recordings.GABAA receptor subtype selectivity of the proconvulsant rodenticide TETS.Visual Evoked Potential Recordings in Mice Using a Dry Non-invasive Multi-channel Scalp EEG Sensor.
P2860
Q28115275-C1EAB1DA-C20E-4317-B453-B12A092B636BQ30529898-F6C83354-BDC2-4162-A683-495D16CBD602Q35600442-F44D77CE-AE3A-4F33-A453-51A14684EB43Q36719106-1FDB675B-7C4A-413E-8BBF-0E65E06629AAQ37284693-7688E74D-4CC3-4496-9201-6A5AA8536A9DQ37404219-ED518D7F-F2D2-49FC-8327-D48E844C0856Q37679357-D97A0426-39F8-4CDD-A7FE-E3A04FFEED61Q46217028-6C7D2972-ADFD-401A-A626-05DD71E30372Q49826644-A37696B3-6B91-46CB-A78D-63EDB101C80A
P2860
Pharmacologic evidence for abnormal thalamocortical functioning in GABA receptor beta3 subunit-deficient mice, a model of Angelman syndrome.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Pharmacologic evidence for abn ...... a model of Angelman syndrome.
@en
Pharmacologic evidence for abn ...... a model of Angelman syndrome.
@nl
type
label
Pharmacologic evidence for abn ...... a model of Angelman syndrome.
@en
Pharmacologic evidence for abn ...... a model of Angelman syndrome.
@nl
prefLabel
Pharmacologic evidence for abn ...... a model of Angelman syndrome.
@en
Pharmacologic evidence for abn ...... a model of Angelman syndrome.
@nl
P2093
P2860
P1433
P1476
Pharmacologic evidence for abn ...... a model of Angelman syndrome.
@en
P2093
Adrian Handforth
Richard W Olsen
Timothy M Delorey
P2860
P304
P356
10.1111/J.1528-1167.2005.00287.X
P577
2005-12-01T00:00:00Z